Using the Medtronic 780G system for managing type 1 diabetes in children
Title: Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes: AWeSoMe Study Group Prospective Trial
This study is trying to see how well the Medtronic 780G insulin delivery system works for managing type 1 diabetes in children and teens aged 7-18 over six months.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120 (estimated) |
| Ages | 1 Year to 21 Years |
| Sex | All |
| Sponsor | Sheba Medical Center Government |
| Locations | 1 site (Ramat Gan, Please Select) |
| Trial ID | NCT05908708 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather data on Israeli children and youth aged 7-18 years who are using the Medtronic 780G closed-loop insulin delivery system. It will assess glycemic control, psychosocial aspects, and various health parameters over a six-month period. Participants will be monitored at baseline, one month, three months, and six months after starting the system. The study involves multiple pediatric diabetes clinics in Israel and focuses on patients who have chosen to use the 780G system as part of their diabetes management.
Who should consider this trial
Good fit: Ideal candidates are children and youth aged 7-18 years diagnosed with type 1 diabetes who are starting the Medtronic 780G system.
Not a fit: Patients under the age of 1 year or those not using the 780G system will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved glycemic control and better psychosocial outcomes for children with type 1 diabetes.
How similar studies have performed: Other studies have shown positive outcomes with similar closed-loop insulin delivery systems, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Diagnosis of type 1 diabetes Diabetes duration ≥ 6 months Routine attendance at clinic visits Initiation of 780G system usage Exclusion Criteria: Children under the age of 1 year Children without 780G system
Where this trial is running
Ramat Gan, Please Select
- Sheba Medical Center — Ramat Gan, Please Select, Israel (Recruiting)
Study contacts
- Study coordinator: Noah Gruber, MD
- Email: noah.gruber@sheba.health.gov.il
- Phone: +972507181666
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.